EP2117573A4 - Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof - Google Patents

Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Info

Publication number
EP2117573A4
EP2117573A4 EP08727595A EP08727595A EP2117573A4 EP 2117573 A4 EP2117573 A4 EP 2117573A4 EP 08727595 A EP08727595 A EP 08727595A EP 08727595 A EP08727595 A EP 08727595A EP 2117573 A4 EP2117573 A4 EP 2117573A4
Authority
EP
European Patent Office
Prior art keywords
cupredoxins
mutants
compositions
methods
conditions related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08727595A
Other languages
German (de)
French (fr)
Other versions
EP2117573A2 (en
Inventor
Anita Chaudhari
Ananda Chakrabarty
Gupta Tapas Das
Arsenio Fialho
Tohru Yamada
Yonghua Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois filed Critical University of Illinois
Publication of EP2117573A2 publication Critical patent/EP2117573A2/en
Publication of EP2117573A4 publication Critical patent/EP2117573A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
EP08727595A 2007-01-11 2008-01-11 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof Withdrawn EP2117573A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87980407P 2007-01-11 2007-01-11
PCT/US2008/050892 WO2008086523A2 (en) 2007-01-11 2008-01-11 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Publications (2)

Publication Number Publication Date
EP2117573A2 EP2117573A2 (en) 2009-11-18
EP2117573A4 true EP2117573A4 (en) 2011-02-16

Family

ID=39609387

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08727595A Withdrawn EP2117573A4 (en) 2007-01-11 2008-01-11 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Country Status (2)

Country Link
EP (1) EP2117573A4 (en)
WO (1) WO2008086523A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2007018671A2 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US20080221015A1 (en) * 2001-02-15 2008-09-11 Anita Chaudhari Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515850A (en) * 2004-10-07 2008-08-12 Ananda Chakrabarty transport agents derived from cupredoxin and methods of using them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221015A1 (en) * 2001-02-15 2008-09-11 Anita Chaudhari Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2007018671A2 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAUDHARI ANITA ET AL: "Cupredoxin-cancer interrelationship: Azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth", BIOCHEMISTRY, vol. 46, no. 7, February 2007 (2007-02-01), pages 1799 - 1810, XP002613162, ISSN: 0006-2960 *
KOOLPE M ET AL: "EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US, vol. 280, no. 17, 18 February 2005 (2005-02-18), pages 17301 - 17311, XP002390919, ISSN: 0021-9258, DOI: 10.1074/JBC.M500363200 *

Also Published As

Publication number Publication date
WO2008086523A2 (en) 2008-07-17
EP2117573A2 (en) 2009-11-18
WO2008086523A3 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
IL187138A0 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
HRP20140203T1 (en) Compositions and methods to enhance the immune system
PL2137210T3 (en) Novel method and compositions
EP2144612A4 (en) Methods and compositions for treating diseases and conditions associated with mitochondrial function
ZA200905508B (en) Compositions and methods to prevent cancer with cupredoxins
IL210559A0 (en) Novel compositions and methods
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
EP2043671A4 (en) Method and compositions for treating stroke with fever
GB0709781D0 (en) Composition and method
IL210588A0 (en) Novel compositions and methods
EP2234625A4 (en) Compositions and methods for treating and preventing skeletal muscle deficiencies
GB0724967D0 (en) Composition and method
EP2294199A4 (en) Compositions and methods for improving plants
EP2370091A4 (en) Compositions and methods relating to mir-31
GB0817585D0 (en) Novel compositions and methods
EP2488642A4 (en) Compositions and methods for the treatment of drug-induced hand-foot syndrome
IL213636A0 (en) Compositions and methods to prevent cancer with cupredoxins
IL214757A0 (en) Compositions and methods to prevent and/or treat cancer with pa-card
IL213657A0 (en) Compositions and methods to prevent cancer with cupredoxins
EP2059122A4 (en) Methods and compositions related to apobec-1 expression
EP2117573A4 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
ZA200709939B (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
GB2467373B (en) Composition and method for determining the water content present in oil
GB0714599D0 (en) Composition and methods relating to photopolymer
ZA200808864B (en) Methods and apparatus to facilitate component installation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090728

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHU, YONGHUA

Inventor name: FIALHO, ARSENIO

Inventor name: YAMADA, TOHRU

Inventor name: DAS GUPTA, TAPAS

Inventor name: CHAKRABARTY, ANANDA

Inventor name: CHAUDHARI, ANITA

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121009